주식/증권 ➡️ 중립 Allogene outlines plan for ~100 ALPHA3 sites by year end as FDA grants RMAT and Fast Track for cema-cel Seeking Alpha - Market News 2026/08/12 23:37:58 74회 원문 기사 보기